165 related articles for article (PubMed ID: 33355861)
21. Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.
Carli G; Visco C; Falisi E; Perbellini O; Novella E; Giaretta I; Ferrarini I; Sandini A; Alghisi A; Ambrosetti A; Rodeghiero F
Ann Hematol; 2016 May; 95(6):863-70. PubMed ID: 27001309
[TBL] [Abstract][Full Text] [Related]
22. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.
García-Marco JA; Jiménez JL; Recasens V; Zarzoso MF; González-Barca E; De Marcos NS; Ramírez MJ; Parraga FJP; Yañez L; De La Serna Torroba J; Malo MDG; Ariznavarreta GD; Persona EP; Guinaldo MAR; De Paz Arias R; Llanos EB; Jarque I; Valle MDCF; Tatay AC; De Oteyza JP; Martin EMD; Fernández IP; Martinez RM; Costa MAA; Champ D; Suarez JG; Díaz MG; Ferrer S; Carbonell F; García-Vela JA;
Haematologica; 2019 Nov; 104(11):2249-2257. PubMed ID: 30890600
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune cytopenias in chronic lymphocytic leukemia.
D'Arena G; Guariglia R; La Rocca F; Trino S; Condelli V; De Martino L; De Feo V; Musto P
Clin Dev Immunol; 2013; 2013():730131. PubMed ID: 23690826
[TBL] [Abstract][Full Text] [Related]
24. Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: a multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS).
Quinquenel A; Willekens C; Dupuis J; Royer B; Ysebaert L; De Guibert S; Michallet AS; Feugier P; Guieze R; Levy V; Delmer A
Am J Hematol; 2015 Mar; 90(3):204-7. PubMed ID: 25428829
[TBL] [Abstract][Full Text] [Related]
25. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
26. A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia.
Kaufman M; Limaye SA; Driscoll N; Johnson C; Caramanica A; Lebowicz Y; Patel D; Kohn N; Rai K
Leuk Lymphoma; 2009 Jun; 50(6):892-9. PubMed ID: 19391041
[TBL] [Abstract][Full Text] [Related]
27. Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients.
Neal TF; Tefferi A; Witzig TE; Su J; Phyliky RL; Nagorney DM
Am J Med; 1992 Oct; 93(4):435-40. PubMed ID: 1415307
[TBL] [Abstract][Full Text] [Related]
28. Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia.
Ruchlemer R; Wotherspoon AC; Thompson JN; Swansbury JG; Matutes E; Catovsky D
Br J Haematol; 2002 Sep; 118(4):952-8. PubMed ID: 12199772
[TBL] [Abstract][Full Text] [Related]
29. Chronic lymphocytic leukemia and autoimmunity: a systematic review.
Hodgson K; Ferrer G; Montserrat E; Moreno C
Haematologica; 2011 May; 96(5):752-61. PubMed ID: 21242190
[TBL] [Abstract][Full Text] [Related]
30. Role of splenectomy in chronic lymphocytic leukaemia with massive splenomegaly and cytopenia.
Majumdar G; Singh AK
Leuk Lymphoma; 1992 May; 7(1-2):131-4. PubMed ID: 1472923
[TBL] [Abstract][Full Text] [Related]
31. The prognostic role of CD5 negativity in B-cell chronic lymphocytic leukaemia: a case-control study.
Efstathiou S; Tsioulos D; Zacharos I; Tsiakou A; Mastorantonakis S; Salgami E; Katirtzoglou N; Psarra A; Roussou P
Haematologia (Budap); 2002; 32(3):209-18. PubMed ID: 12611481
[TBL] [Abstract][Full Text] [Related]
32. A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
Strati P; Caligaris-Cappio F
Curr Opin Oncol; 2011 Sep; 23(5):455-60. PubMed ID: 21681094
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Zent CS; Ding W; Schwager SM; Reinalda MS; Hoyer JD; Jelinek DF; Tschumper RC; Bowen DA; Call TG; Shanafelt TD; Kay NE; Slager SL
Br J Haematol; 2008 May; 141(5):615-21. PubMed ID: 18373706
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune Cytopenia in CLL: Prognosis and Management in the Era of Targeted Therapies.
Albiol N; Moreno C
Cancer J; 2021 Jul-Aug 01; 27(4):286-296. PubMed ID: 34398555
[TBL] [Abstract][Full Text] [Related]
35. [Chronic lymphocytic leukemia accompanied by renal failure].
Dzhumbaeva BT; Biriukova LS; Gemdzhian EG; Kravchenko SK; Melikian AL; Roshtina LS
Ter Arkh; 2014; 86(12):37-41. PubMed ID: 25804038
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia in India--a clinico-hematological profile.
Agrawal N; Naithani R; Mahapatra M; Panigrahi I; Kumar R; Pati HP; Saxena R; Choudhary VP
Hematology; 2007 Jun; 12(3):229-33. PubMed ID: 17558698
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T-cell and T-helper 17 balance in chronic lymphocytic leukemia progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2015; 56(8):2424-8. PubMed ID: 25393804
[TBL] [Abstract][Full Text] [Related]
38. Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.
Schulz H; Klein SK; Rehwald U; Reiser M; Hinke A; Knauf WU; Aulitzky WE; Hensel M; Herold M; Huhn D; Hallek M; Diehl V; Engert A;
Blood; 2002 Nov; 100(9):3115-20. PubMed ID: 12384407
[TBL] [Abstract][Full Text] [Related]
39. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
40. Effective treatment with rituximab in a patient with refractory prolymphocytoid transformed B-chronic lymphocytic leukemia and Evans syndrome.
Seipelt G; Böhme A; Koschmieder S; Hoelzer D
Ann Hematol; 2001 Mar; 80(3):170-3. PubMed ID: 11320903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
